Evidence map›Paper›PMID 30093730›Full record

ArticleNature medicine2018

Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition.

Gabrielle S Wong, Jin Zhou, Jie Bin Liu, Zhong Wu, Xinsen Xu, Tianxia Li, David Xu, Steven E Schumacher, Jens Puschhof, James McFarland and 28 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

38 authors.

Gabrielle S WongDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Jin Zhou *Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Jie Bin Liu *Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Zhong WuDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Xinsen XuDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Tianxia LiDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
David XuDepartment of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center and Biological Sciences, Chicago, IL, USA.
Steven E SchumacherCancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Jens PuschhofDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
James McFarlandDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Charles ZouDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Austin DulakDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Les HendersonDepartment of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center and Biological Sciences, Chicago, IL, USA.
Peng XuDepartment of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center and Biological Sciences, Chicago, IL, USA.
Emily O'DayDepartment of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center and Biological Sciences, Chicago, IL, USA.
Rachel RendakDepartment of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center and Biological Sciences, Chicago, IL, USA.
Wei-Li LiaoOncoPlex Diagnostics/NantOmics, Rockville, MD, USA.
Fabiola CecchiOncoPlex Diagnostics/NantOmics, Rockville, MD, USA.
Todd HembroughOncoPlex Diagnostics/NantOmics, Rockville, MD, USA.
Sarit SchwartzOncoPlex Diagnostics/NantOmics, Rockville, MD, USA.
Christopher SzetoOncoPlex Diagnostics/NantOmics, Rockville, MD, USA.
Anil K RustgiDivision of Gastroenterology, Departments of Medicine and Genetics, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Kwok-Kin WongDepartment of Medicine, Harvard Medical School, Boston, MA, USA.
J Alan DiehlDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.ORCID http://orcid.org/0000-0001-9854-5049
Karin JensenSanofi Oncology, Cambridge, MA, USA.
Francesco GrazianoDepartment of Biomolecular Sciences, University of Urbino "Carlo Bo", Urbino, Italy.
Annamaria RuzzoDepartment of Biomolecular Sciences, University of Urbino "Carlo Bo", Urbino, Italy.
Shaunt FereshetianCancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Philipp MertinsCancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Steven A CarrCancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-7203-4299
Rameen BeroukhimDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Kenichi NakamuraDepartment of Gastroenterological Surgery, Kumamoto University, Kumamoto, Japan.
Eiji OkiDepartment of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Masayuki WatanabeDepartment of Gastroenterological Surgery, Kumamoto University, Kumamoto, Japan.
Hideo BabaDepartment of Gastroenterological Surgery, Kumamoto University, Kumamoto, Japan.
Yu ImamuraDepartment of Gastroenterological Surgery, Kumamoto University, Kumamoto, Japan.
Daniel CatenacciDepartment of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center and Biological Sciences, Chicago, IL, USA. dcatenac@bsd.uchicago.edu.
Adam J BassDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. adam_bass@dfci.harvard.edu.

Funding

Therapeutic strategies for specific subsets of KRAS mutant lung cancersR01CA140594 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI WONG, KWOK KIN · 2009 to 2017
$4.5M
6 · The paper itself

Abstract

In the Supplementary Information originally published with this article, a lane was missing in the β-actin blot in Supplementary Fig. 2. The lane has been added. The error has been corrected in the Supplementary Information associated with this article.

Identifiers

PMID30093730

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.